Carfilzomib promotes the osteogenic differentiation potential of mesenchymal stem cells derived from myeloma patients by inhibiting notch1 activity in vitro-Reference-Cited by-同舟云学术

Carfilzomib promotes the osteogenic differentiation potential of mesenchymal stem cells derived from myeloma patients by inhibiting notch1 activity in vitro

Published:2014-08 Issue:8 Volume:38 Page:970-976
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Li Yali,Li Jun,Zhuang Wenzhuo,Wang Qian,Ge Xueping,Zhang Xiaohui,Chen Ping,Fu Jinxiang,Li Bingzong

Funder

National Natural Science Foundation of China

Applied Basic Research Programs of Suzhou City

China Postdoctoral Science Foundation

Foundation for Doctors and Returned Scholars of Second Affiliated Hospital of Soochow University

Jiangsu Province's Key Medical Department

Priority Academic Program Development of Jiangsu Higher Education Institutions

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference29 articles.

1. Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment;Giuliani;Blood,2001

2. Osteoblast function in myeloma;Roodman;Bone,2011

3. New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-kappaB ligand (RANKL);Giuliani;Exp Hematol,2004

4. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement;Horwitz;Cytotherapy,2005

5. Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effects;Reagan;Clin Cancer Res,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carfilzomib alleviated osteoporosis by targeting PSME1/2 to activate Wnt/β-catenin signaling;Molecular and Cellular Endocrinology;2022-01

2. Myeloma Bone Disease: A Comprehensive Review;International Journal of Molecular Sciences;2021-06-08

3. The Role of Proteasome Inhibitors in Multiple Myeloma Bone Disease and Bone Metastasis: Effects on Osteoblasts and Osteocytes;Applied Sciences;2021-05-19

4. Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study;Cancers;2021-03-12

5. The Proteasome and Myeloma-Associated Bone Disease;Calcified Tissue International;2017-10-28